Sukhatme VP - Search Results

1

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Maynard SE, et al. Among authors: sukhatme vp. J Clin Invest. 2003 Mar;111(5):649-58. doi: 10.1172/JCI17189. J Clin Invest. 2003. PMID: 12618519 Free PMC article.

2

First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. Thadhani R, et al. Among authors: sukhatme vp. J Clin Endocrinol Metab. 2004 Feb;89(2):770-5. doi: 10.1210/jc.2003-031244. J Clin Endocrinol Metab. 2004. PMID: 14764795

3

Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights.

Bdolah Y, Sukhatme VP, Karumanchi SA. Bdolah Y, et al. Among authors: sukhatme vp. Semin Nephrol. 2004 Nov;24(6):548-56. doi: 10.1016/s0270-9295(04)00125-1. Semin Nephrol. 2004. PMID: 15529289 Review.

4

Preeclampsia: a renal perspective.

Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Karumanchi SA, et al. Among authors: sukhatme vp. Kidney Int. 2005 Jun;67(6):2101-13. doi: 10.1111/j.1523-1755.2005.00316.x. Kidney Int. 2005. PMID: 15882253 Free article. Review.

5

Soluble endoglin contributes to the pathogenesis of preeclampsia.

Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Venkatesha S, et al. Among authors: sukhatme vp. Nat Med. 2006 Jun;12(6):642-9. doi: 10.1038/nm1429. Epub 2006 Jun 4. Nat Med. 2006. PMID: 16751767

6

Renal cancer: molecular mechanisms and newer therapeutic options.

Karumanchi SA, Merchan J, Sukhatme VP. Karumanchi SA, et al. Among authors: sukhatme vp. Curr Opin Nephrol Hypertens. 2002 Jan;11(1):37-42. doi: 10.1097/00041552-200201000-00006. Curr Opin Nephrol Hypertens. 2002. PMID: 11753085 Review.

7

Circulating angiogenic factors and the risk of preeclampsia.

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Levine RJ, et al. Among authors: sukhatme vp. N Engl J Med. 2004 Feb 12;350(7):672-83. doi: 10.1056/NEJMoa031884. Epub 2004 Feb 5. N Engl J Med. 2004. PMID: 14764923 Free article.

8

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, Rajakumar A, Daftary A, Shakir AS, Seely EW, Roberts JM, Sukhatme VP, Karumanchi SA, Thadhani R. Wolf M, et al. Among authors: sukhatme vp. J Clin Endocrinol Metab. 2004 Dec;89(12):6239-43. doi: 10.1210/jc.2004-0548. J Clin Endocrinol Metab. 2004. PMID: 15579783

9

Urinary placental growth factor and risk of preeclampsia.

Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Levine RJ, et al. Among authors: sukhatme vp. JAMA. 2005 Jan 5;293(1):77-85. doi: 10.1001/jama.293.1.77. JAMA. 2005. PMID: 15632339

10

Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans.

Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Parikh SM, et al. Among authors: sukhatme vp. PLoS Med. 2006 Mar;3(3):e46. doi: 10.1371/journal.pmed.0030046. PLoS Med. 2006. PMID: 16417407 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters